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Background  
Over the past few decades, we have seen several outbreaks of 
zoonotic coronavirus infections. These viruses have the 
potential of interspecies transmission leading to pathogenesis 
in humans. This particular respiratory coronavirus initially 
named 2019-nCOV, is known as severe acute respiratory 
syndrome coronavirus-2 (SARS-CoV-2). Later, the World 
Health Organization (WHO) named this pandemic as 
Coronavirus disease 2019 (COVID-19). Individuals who were 
exposed to a wet market in Wuhan, China, were initially 
diagnosed with the disease. Similar to two previous outbreaks, 
severe acute respiratory syndrome coronavirus [SARS-CoV] 
and Middle East respiratory syndrome coronavirus [MERS-
CoV], COVID-19 also causes respiratory illness [1]. The 
initial reports indicated that human-to-human transmission of 
this disease was limited, but soon it became evident that 
COVID-19 could spread through person-to-person contact 
more harshly in communities where there are mass gatherings 
[2]. 
Consequently, the disease was quickly transmitted to other 
geographical regions through infected travelers. The clinical 
course, the spectrum of illness, and severity of COVID-19 
include three significant patterns: (1) mild illness presented 
with symptoms of upper respiratory tract infection; (2) non-
life-threatening pneumonia; and (3) severe pneumonia 
manifested with acute respiratory distress syndrome which 
necessitates advanced life support. The most common 
symptoms are fever, cough and shortness of breath. The 
current evidence suggests that the incubation period after 
exposure to the COVID-19 virus is supposed to be within two 
weeks, and the median incubation period with symptomatic 
presentation appears around 5 days post-exposure [2-4].  
It is known that the genome size of coronaviruses is largest 
among all identified RNA viruses and so these viruses are 
capable of recombination (homologous and non-homologous), 
which makes them more vulnerable for mutations. The initial 
genome sequence analysis of the nine patients with SARS-
CoV-2 revealed 99·9% sequence identity which belongs to 
subgenus Sarbecovirus [5]. Recently, Zhu et al. [6] have 
isolated COVID-19 nucleic acid and characterized its 
complete genome by using high-throughput sequencing and 
bioinformatics. The results of initial phylogenetic analysis, 
together with other studies, demonstrated that the novel 
coronavirus has 75-80% similarity with the SARS-CoV and is 
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also closely related to the pathogenic coronavirus infecting 
bats and other wild animals [7]. Furthermore, structural 
analysis of various COVID-19 samples from China revealed 
two types of SARS-CoV-2 strains designated as ‘type L,’ 
which constituted 70% of the strains, while the remaining 30% 
accounted for ‘type S’ strain [8]. During the initial outbreak in 
China, ‘type L’ predominated mainly in the Wuhan region, 
and so, this strain was less likely to be identified outside of 
Wuhan. The clinico-epidemiological implications of these 
findings necessitate further investigation. Current studies have 
also suggested that COVID-19 can be potentially transmitted 
through aerosol and fomite. The virus could remain contagious 
in the aerosols for up to 3 hours and remains viable on hard 
surfaces such as plastic and stainless steel for about 72 hours 
[9]. 
The diagnostic testing for COVID-19 includes three main 
strategies such as (a) detection of the virus using Reverse 
Transcriptase Polymerase Chain Reaction (RT-PCR) (b) 
detection of antibodies (IgM/IgG) to the virus using Enzyme-
linked immunosorbent assay (ELISA) and (c) imaging 
modalities like CT scan to identify the extent of lung 
involvement. Among the different clinical specimens, 
bronchoalveolar lavage (93%) has the highest positivity rate 
for SARS-CoV-2 followed by sputum (72%) and nasal swabs 
(63%). 
The experimental studies found that COVID-19 multiplies 
efficiently in primary human airway epithelial cells, which 
could be used for pre-clinical studies. Therefore, a better 
understanding of the novel viral characteristics and pathogenic 
domains allow researchers to develop rapid and highly 
sensitive diagnostic test and facilitate the invention of novel 
vaccines and antiviral therapies. Notably, the development of 
specific diagnostic assays will be more appropriate to assess 
the disease prevalence among humans and other zoonotic 
species responsible for the virus transmission. In the recent 
development for diagnostic assays, a commercial Covid-19 
diagnostic (RT-PCR) test kits which is first of its kind in India 
has been approved by the Indian FDA / Central Drugs 
Standard Control Organisation (CDSCO). Finally, molecular 
characterization of the virus, together with bioinformatics, 
may aid in developing novel vaccines and antiviral therapies 
based on experimental studies. 
Epidemiology of COVID-19 
The WHO declared COVID-19 as a pandemic on the 21st of 
March 2020, when a total of 183,112 cases were reported 
worldwide in 163 countries with 11,890 deaths [10]. China, 
where the first cluster of COVID-19 patients was discovered, 
has reported 81,394 cases and 3,295 deaths as of March 28, 
2020. Italy reported most deaths outside China; 10,023 deaths 
out of 92,472 cases. The United States is currently leading the 
total number of confirmed cases worldwide. The overall 
mortality rate was 2.4 per million populations.When compared 
to China, the incidence rate of COVID-19 (1,529 vs. 57 per 
million population) and mortality (166 vs. 2 per million 
population) was considerably higher in Italy. The median age 
of the patients was 47 years (IQR 35-58), and nearly 60% were 
males [4]. The majority (81%) of the cases were mild (no or 
mild pneumonia); 14% were severe with dyspnea, hypoxia, or 
>50 percent lung involvement on imaging within 24 to 48 
hours. Patients with severe disease reported to have respiratory 
failure, shock, or multi-organ dysfunction (5%). No deaths 
were reported among noncritical cases [11]. Nearly a quarter 
of the patients (23.7%) were having underlying comorbidities, 
which included hypertension (15%), diabetes (7.4%), and 
coronary heart disease (2.5%) [4,11]. The WHO stressed the 
need for immediate aggressive preventive measures to slow 
down COVID-19 among South-East Asia to slow down the 
steady increase in disease transmission. To date, the number of 
COVID-19 cases in South Asia has so far remained low, but 
there are predictions that this situation may get worst in the 
coming days. Collectively, the South Asian countries have 
around 2723 confirmed cases of COVID-19 (Pakistan 1495, 
India 933, Sri Lanka 113, Afghanistan 110, Bangladesh 48, 
Maldives 16, Bhutan 3 and five cases in Nepal) as of 28th 
March 2020. In India, the selective use of hydroxychloroquine 
for prophylaxis among high-risk healthcare professionals and 
caregivers has been recently approved by the Indian Council 
of Medical Research (ICMR). 
COVID-19 in Nepal 
Nepal is among one of the nine countries that reported just five 
cases of COVID-19 as of March 28, 2020. Most COVID-19 
cases are handled and treated at Sukraraj Tropical and 
Infectious Disease Hospital and the SARS-CoV-2 testing is 
being done at the Nepal Public Health Laboratory in 
Kathmandu. The first positive case of COVID-19 in Nepal 
was reported on January 13, 2020, in a 32-year-old Nepalese 
student based at Wuhan University of Technology, with no 
known comorbidities who had returned to Nepal [12]. The 
patient presented at a hospital in Kathmandu, complaining of  
cough. He had developed symptoms six days before his travel 
to Nepal. Throat swabs taken from the patient were found to 
be positive for COVID-19 using real-time quantification 
assays performed at the WHO laboratory in Hong Kong. 
Fortunately, the patient recovered 13 days post-exposure. The 
second case was confirmed on 23rd March 2020. This was a 
19-year old female student who returned to Nepal from France 
via Qatar on March 17. The third case of Coronavirus was 
tested positive on 25rd march 2020 who is a 32-year-old male 
returned from United Arab Emirates on March 19. He stayed 
at a hotel in Kathmandu and later confirmed for COVID-19 . 
On March 27, 2020, the fourth case was test positive which is 
among the first confirmed case outside the Kathmandu valley. 
This patients is a 37-year-old male returned recently from the 
Middle East. The fifth case is a 19-year-old female who 
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travelled to Kathmandu from Belgium via Qatar and was 
confirmed on March 28, 2020. This patient had travelled with 
the patient who was diagnosed on March 23 (in the same flight 
from Doha to Kathmandu). 
Considering the risk of COVID-19 transmission, the  
government of Nepal has initiated various preventive 
measures. Several districts including Kathmandu are in lock-
down where people are asked stay at home except for 
emergency reasons. Dedicated health-desks have been set-up 
at the international airport and on the border checkpoints with 
India and china. All foreign nationals who enter Nepal must 
remain in self-quarantine for 14 days and all international 
flights have been  suspended. The government of Nepal has 
stopped all promotional campaigns such as ‘Visit Nepal 
2020’;‘Sagarmatha Sambad 2020’ and others international 
events. 
Having only five cases of COVID-19 in Nepal is, of course, 
unrealistic, especially considering the high influx of Chinese 
either as a tourist or as a worker, through several border 
crossing points, and unrestricted migration of tourists from 
countries with severe outbreak mainly from South Korea, 
Italy, Spain, Japan, and France till 9th of March 2020. The low 
incidence may reflect improper diagnoses due to the absence 
of testing. We are still in the early stage of the pandemic, so 
infection and mortality rates are bound to rise considerably. 
Therefore, it is a crucial time for governments to implement 
stringent measures to control the spread further. 
Challenges to contain COVID-19 spread in Nepal 
There are various public health challenges in controlling the 
spread of COVID-19 in South Asian region, including Nepal. 
Learning from the COVID-19 outbreak in China, there will be 
a slowdown of economic activity with damaged supply chains 
that impact the public health systems in Nepal. Moreover, 
there is limited coordination among different stakeholders in 
healthcare management with few policies in place for infection 
prevention and control (IPC), shortage of testing kits, medical 
supplies, personal protective equipment, and poor reporting 
are major challenges to be tackled in case of the COVID-19. 
Most South Asian countries are vulnerable to a mass outbreak 
owing to high population density in cities, where it is more 
challenging to maintain social distancing, poor hygiene and 
lower (health) literacy rate. Additionally, some COVID-19 
cases remain asymptomatic, so it is difficult to predict the 
severity of the outbreak.  
Recommendations 
Currently, there is a need to allocate resources, manpower and 
stricter regulations to contain the COVID-19. The WHO has 
published a set of preventive guidelines on COVID-19 for 
health workers [13]. Importantly, the healthcare staff should be 
trained to tackle complex situations and challenges associated 
with the disease outbreak and to implement strict IPC 
measures to avoid transmission. The intensive awareness 
campaign for surveillance, quarantine, and diagnosis should be 
rolled out. Additionally, there is a need to focus on guidelines, 
education, and training for IPC through multifaceted 
strategies, regular monitoring, review of practices and 
feedback, staffing, and bed occupancy in acute healthcare 
settings.  
The management for COVID-19 primarily comprized of 
supportive care. So, home management may be possible for 
patients with mild illness who should be properly isolated. To 
futher reduce the risk of transmission in the community, 
individuals should maintain hand hygiene, avoid touching 
eyes, nose, and mouth, cover the face while coughing or 
sneezing and avoid close contact with sick individuals. Due to 
short supply, face masks (preferably N95) are only advised for 
healthcare professionals and individuals with symptoms of 
respiratory distress. Unless appropriately worn, the face masks 
are ineffective for preventing the disease exposure. Social 
distancing is advised in locations that are at higher risk of 
community transmission, as one should keep at least 1½ to 2 
meters distance from another person.   
In the current situation, abiding the general health guidelines is 
utmost important to maintain stronger immunity to fight 
infection and protection from other environmental hazards. 
The healthy lifestyle practice includes good eating habits, 
regular exercise, control of stress and blood pressure level, 
avoidance of smoking and drinking alcohol and get enough 
sleep. However, this means Nepal also needs to address health 
inequality and poverty which are existing public health issues 
in the country. Poor people have fewer opportunities to eat 
well, maintain hygeine and keep social distance from ill. 
Finally, collaboration between national agencies in Nepal with 
international organizations such as the CDC and WHO [13] 
can help to contain the spread of COVID-19 through global 
best practices. 
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